Summary. The effects of the host's immune response on metastatic spread was investigated by observing the numbers of pulmonary metastases that developed from an s.c. implant of the Lewis lung carcinoma in C57BL mice in which different cell populations had been suppressed. Macrophage function was impaired by treatment with silica (Si), cortisone acetate (CA), or trypan blue (TB). T-cell function was depressed by adult thymectomy and sublethal irradiation, or by treatment with antilymphocyte serum (ALS).
ALTHOUGH successful treatment of patients with primary neoplasms is often possible, death frequently occurs from disseminated tumour. However, there is evidence from animal studies that the immunological response of the host deals more effectively with distant foci than with a single primary tumour (Milas et al., 1974) and immunotherapy may be more effective in this situation.
Killed Corynebacteriurn parvum is a powerful immunopotentiating agent (Halpern et al., 1963; Biozzi et al., 1968; Howard, Christie and Scott, 1973) and it inhibits the growth of a variety of primary and metastatic rodent tumours (Halpern et al., 1966; Woodruff and Boak, 1966; Smith and Scott, 1972; Proctor, Rudenstam and Alexander, 1973; Sadler and Castro, 1976) .
To investigate the effects of the host's immune response on disseminated tumour and in the antimetastatic action of C. parvum, mice bearing the metastasizing Lewis lung carcinoma were treated to suppress selectively the separate components of this response. Tumour.-The Lewis lung carcinoma (Sugiura and Stock, 1955) was transplanted s.c. as a 0 1-ml homogenate in the lower flank. When implanted s.c., it metastasizes to the lungs (Simpson-Herren, Sanford and Holmquist, 1974) . Twenty-one days after tumour inoculation, the number of metastases was determined after inflating the lungs with a dilute solution of indian ink and fixing in Fekete's solution (Wexler, 1966) . Lungs with >100 metastases were scored as having 100. (Scott, 1975) (Hibbs, 1975 Thymectomy and irradiation.-Adult mice were thymectomized under Nembutal anaesthesia (Castro, 1974) . Two weeks later they received 450R whole-body sublethal irradiation. Tumour was inoculated after a further 4 weeks.
Antilymphocyte serum.-025 ml rabbit anti-AKR mouse thymocyte serum (ALS) (Searle Diagnostics Ltd, Batch 10-prepared by a standard 2-pulse inoculation schedule) was given s.c. either on Days -2, -1, 0, +7, +14 or on Days +5, +6, +7 and +14 from tumour implantation. Control mice received normal rabbit serum (NRS).
C. parvum.-A formalin-killed suspension of C. parvum (Wellcome, Strain CN 6134, (Batch PX416 for CA studies, Batch PX374 for all others) 7 mg dry wt/ml) was used at a concentration of 2-33 mg/ml in 0-15 M saline. Mice receiving C. parvum were given 0-2 ml i.v. into a lateral tail vein on the same day as tumour implantation, or 7 days later. Control mice received the same volume of 0-15 M saline.
RESULTS
C. parvum administered on Day 0 or Day + 7 was equally effective at inhibiting pulmonary metastasis (significance P < 0-001) ( Table I ).
Macrophage impairment
Macrophage activity was impaired with silica (Si), cortisone acetate (CA), or trypan blue (TB) (see Table I ). cantly increased after C. parvurn (Fig. 1) . C. parvum in combination with Si increased the index to a value intermediate to that of untreated and C. parvumtreated tumour-bearing mice. Si on Days -I and + 4 had more effect on metastases, increasing them from 38 in controls to 100-k (P < 0-001). C. parvum given on Day 0 to mice treated with Si reduced metastases from 100+ to 51 (P < 0.001). However, there was no significant difference between the number of metastases found in these mice and saline-treated controls, and in both groups the number was significantly higher than in mice given C. parvum alone (mean 12, P < 0-001). Phagocytic index was again reduced for a short time after Si and increased after C. parvum (Fig.  2) , whereas after Si and C. parvum in combination, it was not significantly different from thatin untreated tumour-bearing mice. In mice given 2 doses of CA, C. parvum inhibited metastases from 92 to 37 (P < 0-001), but this number was higher than that found in mice given C. parvum alone (mean 11, P < 0-001) and not significantly different from that found in saline-treated controls (mean 50).
The phagocytic index (Fig. 3 (Table III) . (Pearsall and Weiser, 1968; Levy and Wheelock, 1975 (Claman, 1972) . TB inhibits lysosomal enzymes of macrott received phages (Beck, Lloyd and Griffiths, 1967) metastatic and abrogates non-specific resistance to of meta-growth of ascitic tumour in mice treated 29) was with BCG or toxoplasma (Hibbs, 1975) .
controls
We found that mice were unable P < 0.01). to tolerate more than two doses of Si s delayed at 5-day intervals. Si increased meta-C. parvum stasis, and this was greater when it was ases (from given on Days -1 and + 4 rather than -found in on Days +4 and +9. CA also increased mean 10). metastasis, and this effect was more marked when a second dose was given.
These increases of metastases were not a direct reflection of primary tumour immune growth, as this was depressed (paper in metastasis preparation). A similar increase of lung ;ion of C. tumour nodules has been reported after depressing gold salts, which inhibit lysosomal enzyme ght to be activity of macrophages (McBride, Tuach and Marmion, 1975) . However, in our experiments TB, which has a similar effect on macrophages, did not influence metastasis. This difference is difficult to explain, for doses of TB were similar to those described by Hibbs (1975) who showed facilitation of the growth of an allogeneic mouse tumour. However, we also found the phagocytic index of mice given TB was unchanged, whereas both Si and CA depressed it. Thus a depression of phagocytic index may be necessary for an increase of metastases.
C. parvum significantly decreased metastasis in mice given Si, CA or TB. This result was unexpected, as there is considerable evidence for the involvement of macrophages in the antitumour action of C. parvum (Ghaffar, Cullen and Woodruff, 1975; Christie and Bomford, 1975) . However, measurement of phagocytic index showed C. parvum was able to overcome, to a limited extent, inhibition of macrophage activity produced by Si or CA, probably by increasing macrophage production (Wolmark and Fisher, 1974; Warr and Sljivic, 1974) . Furthermore, metastasis appeared to be inversely related to the host phagocytic activity.
T cells were depressed, either by thymectomy and sublethal irradiation, which depletes mainly short-lived lymphocytes or T1 cells (Kappler et al., 1974) or by treatment with ALS, which destroys mainly long-lived circulating lymphocytes or T2 cells (Lance, Medawar and Taub, 1973; Araneo, Marrack and Kappler, 1975) .
We found that depression of T cells by thymectomy and irradiation did not alter the number of metastases, but Carnaud, Hoch and Trainin (1974) , using the same system, reported a significant increase. Nor did this treatment affect the antimetastatic action of C. parvum.
Depression of T cells by ALS treatment begun 5 days after tumour inoculation had no effect on metastasis, whereas ALS given before and during tumour growth significantly inhibited it. This suggests that, for optimal metastasis, a population of ALS-sensitive T cells is required at the time of tumour inoculation.
ALS given before and during tumour growth abrogated the antimetastatic action of C. parvum. We reported this in our previous paper (Sadler and Castro, 1976 ) in which we also showed that this treatment did not affect the phagocytic index. We suggested that the action of C. parvum on metastases was dependent upon a specific population of T cells present in mice thymectomized and sublethally irradiated, but not in ALS-treated mice. The present study shows that if ALS treatment was begun 5 days after tumour implantation, at a time when tumour cells are first released from the primary tumour (James and Salsbury, 1974) then the antimetastatic action of C. parvum was unaffected. This suggests that although the ALSsensitive cells are not the effector cells in the antimetastatic response, they are necessary in the sensitization arm of this response.
We can therefore conclude from this study that macrophages are important in preventing the natural spread of metastases from a primary tumour. Systemic C. parvum given on the day of tumour implantation or 7 days later, causes an equally drastic reduction in metastases probably through macrophage activation. A sub-population of T cells present in thymectomized and sublethally irradiated, but not ALS-treated mice enhances metastatic spread. A similarly defined population of T cells is necessary for the antimetastatic action of C. parvum, and probably brings about macrophage activation. Further studies are under way to elucidate the precise T-cell populations involved.
